Meta-analysis of the impact of surgical margins on local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy

被引:316
作者
Houssami, Nehmat [1 ]
Macaskill, Petra [1 ]
Marinovich, M. Luke [1 ]
Dixon, J. Michael [2 ]
Irwig, Les [1 ]
Brennan, Meagan E. [1 ]
Solin, Lawrence J. [3 ]
机构
[1] Univ Sydney, STEP, Sch Publ Hlth, Sydney Med Sch, Sydney, NSW 2006, Australia
[2] Western Gen Hosp, Breakthrough Res Unit Edinburgh, Edinburgh EH4 2XU, Midlothian, Scotland
[3] Albert Einstein Med Ctr, Dept Radiat Oncol, Philadelphia, PA 19141 USA
基金
英国医学研究理事会;
关键词
Invasive breast cancer; Breast-conserving therapy; Surgical margins; Local recurrence; Radiation therapy; Surgical oncology; Meta-analysis; 20-YEAR FOLLOW-UP; RADIATION-THERAPY; CONSERVATION THERAPY; REGIONAL RECURRENCE; RANDOMIZED-TRIAL; DEFINITIVE IRRADIATION; ADJUVANT CHEMOTHERAPY; DISTANT METASTASES; TUMOR RECURRENCE; DOSE-ESCALATION;
D O I
10.1016/j.ejca.2010.07.043
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: There is no consensus on what constitutes adequate negative margins in breast-conserving therapy (BCT). We review the evidence on surgical margins in BCT for early-stage invasive breast cancer. Methods: Meta-analysis of studies reporting local recurrence (LR) relative to quantified final microscopic margin status and the threshold distance for negative margins. The proportion of LR was modelled using random effects logistic meta-regression. Results: Based on 21 studies (LR in 1,026 of 14,571 subjects) the odds of LR were associated with margin status [model 1: odds ratio (OR) = 2.02 for positive/close versus negative; model 2: OR = 1.80 for close versus negative, 2.42 for positive versus negative (P < 0.001 both models)] but not with margin distance [1 mm versus 2 mm versus 5 mm (P > 0.10 both models)], adjusting for median follow-up time. However, there was weak evidence in both models that the odds of LR decreased as the threshold distance for declaring negative margins increased. This bordered significance in model 2 [OR for 1 mm, 2 mm, 5 mm: 1.0, 0.75, 0.51 (P = 0.097 for trend)], and was not significant in model 1 [OR for 1 mm, 2 mm, 5 mm: 1.0, 0.85, 0.58 (P = 0.11 for trend)] but was evident when one study (of women <= 40 years) was excluded from this model [OR for 1 mm, 2 mm, 5 mm: 1.0, 0.72, 0.52 (P = 0.058 for trend)]: this trend was rendered insignificant by adjustment for the proportion of subjects receiving a radiation boost or the proportion of subjects receiving endocrine therapy. Conclusions: Margin status has a prognostic effect in all women treated for invasive breast cancer; increasing the threshold distance for declaring negative margins is weakly associated with reduced odds of LR, however adjustment for covariates (adjuvant therapy) removes the significance of this effect. Adoption of wider margins, relative to narrower widths, for declaring negative margins is unlikely to a have substantial additional benefit for long-term local control in BCT. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3219 / 3232
页数:14
相关论文
共 80 条
[51]   Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy - The National Cancer Institute randomized trial [J].
Poggi, MM ;
Danforth, DN ;
Sciuto, LC ;
Smith, SL ;
Steinberg, SM ;
Liewehr, DJ ;
Menard, C ;
Lippman, ME ;
Lichter, AS ;
Altemus, RM .
CANCER, 2003, 98 (04) :697-702
[52]   Impact of the boost dose of 10 Gy versus 26 Gy in patients with early stage breast cancer after a microscopically incomplete lumpectomy: 10-year results of the randomised EORTC boost trial [J].
Poortman, Philip M. ;
Collette, Laurence ;
Horiot, Jean-Claude ;
Van den Bogaert, Walter F. ;
Fourquet, Alain ;
Kuten, Abraham ;
Noordijk, Evert M. ;
Hoogenraad, Willem ;
Mirimanoff, Rene-Olivier ;
Pierart, Marianne ;
Van Limbergen, Erik ;
Bartelink, Harry .
RADIOTHERAPY AND ONCOLOGY, 2009, 90 (01) :80-85
[53]   Eight-year results of a prospective non-randomised study on therapy of small breast cancer [J].
Rauschecker, HF ;
Sauerbrei, W ;
Gatzemeier, W ;
Sauer, R ;
Schauer, A ;
Schmoor, C ;
Schumacher, M .
EUROPEAN JOURNAL OF CANCER, 1998, 34 (03) :315-323
[54]   The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer [J].
Recht, A ;
Come, SE ;
Henderson, IC ;
Gelman, RS ;
Silver, B ;
Hayes, DF ;
Shulman, LN ;
Harris, JR .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (21) :1356-1361
[55]   The importance of the resection margin in conservative surgery for breast cancer [J].
Renton, SC ;
Gazet, JC ;
Ford, HT ;
Corbishley, C ;
Sutcliffe, R .
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1996, 22 (01) :17-22
[56]   Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer [J].
Romond, EH ;
Perez, EA ;
Bryant, J ;
Suman, VJ ;
Geyer, CE ;
Davidson, NE ;
Tan-Chiu, E ;
Martino, S ;
Paik, S ;
Kaufman, PA ;
Swain, SM ;
Pisansky, TM ;
Fehrenbacher, L ;
Kutteh, LA ;
Vogel, VG ;
Visscher, DW ;
Yothers, G ;
Jenkins, RB ;
Brown, AM ;
Dakhil, SR ;
Mamounas, EP ;
Lingle, WL ;
Klein, PM ;
Ingle, JN ;
Wolmark, N .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (16) :1673-1684
[57]  
Sakamoto Goi, 2005, Breast Cancer, V12 Suppl, pS1
[58]   Fifteen-year results of breast-conserving surgery and definitive irradiation for stage I and II breast carcinoma: The University of Pennsylvania experience [J].
Santiago, RJ ;
Wu, L ;
Harris, E ;
Fox, K ;
Schultz, D ;
Glick, J ;
Solin, LJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 58 (01) :233-240
[59]  
SCHNITT SJ, 1994, CANCER, V74, P1746, DOI 10.1002/1097-0142(19940915)74:6<1746::AID-CNCR2820740617>3.0.CO
[60]  
2-Y